Literature DB >> 12584029

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.

O Kudo1, A Sabokbar, A Pocock, I Itonaga, Y Fujikawa, N A Athanasou.   

Abstract

Interleukin-6 (IL-6) and interleukin-11 (IL-11) are known to influence osteoclast formation and bone resorption. In order to determine whether IL-6 and IL-11 could independently support human osteoclast formation, these factors were added to cultures of human peripheral blood mononuclear cells of the monocyte (CD14(+)) fraction in the presence of macrophage colony-stimulating factor (M-CSF). Under these conditions, IL-6 and IL-11 induced the formation of multinucleated cells which were positive for TRAP, VNR, and calcitonin receptor and capable of lacunar resorption. Osteoclastogenesis induced by IL-6 and IL-11 was inhibited by the addition of an anti-gp130 antibody but not by osteoprotegerin. These results indicate that IL-6 and IL-11, which are thought to play a role in several osteolytic bone disorders, are directly capable of inducing osteoclast formation by a RANKL-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584029     DOI: 10.1016/s8756-3282(02)00915-8

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  134 in total

1.  Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion.

Authors:  Guenther G Steger; Rupert Bartsch
Journal:  Ther Adv Med Oncol       Date:  2011-09       Impact factor: 8.168

Review 2.  Frailty and hormones.

Authors:  John E Morley; Moon Jong Kim; Matthew T Haren
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

3.  Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis.

Authors:  Kenji Ogawa; Masaaki Mawatari; Mitsunori Komine; Masamori Shigematsu; Masaru Kitajima; Akiko Kukita; Takao Hotokebuchi
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

Review 4.  Dendritic cells and cytokines in human inflammatory and autoimmune diseases.

Authors:  Patrick Blanco; A Karolina Palucka; Virginia Pascual; Jacques Banchereau
Journal:  Cytokine Growth Factor Rev       Date:  2008-02       Impact factor: 7.638

5.  Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling.

Authors:  Jong-Ho Lee; Ha-Neui Kim; Daum Yang; Kyoungsuk Jung; Hyun-Man Kim; Hong-Hee Kim; Hyunil Ha; Zang Hee Lee
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

6.  Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts.

Authors:  Kosuke Mizutani; Sudha Sud; Kenneth J Pienta
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

7.  Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood.

Authors:  Julia Cazalis; Shin-ichi Tanabe; Guy Gagnon; Timo Sorsa; Daniel Grenier
Journal:  Inflammation       Date:  2009-04       Impact factor: 4.092

8.  Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis.

Authors:  Robert Nason; Jae Y Jung; Richard A Chole
Journal:  J Assoc Res Otolaryngol       Date:  2009-01-15

9.  Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.

Authors:  Anthony Lucci; Savitri Krishnamurthy; Balraj Singh; Isabelle Bedrosian; Funda Meric-Bernstam; James Reuben; Kristine Broglio; Kailash Mosalpuria; Ashutosh Lodhi; Laura Vincent; Massimo Cristofanilli
Journal:  Breast Cancer Res Treat       Date:  2008-07-29       Impact factor: 4.872

10.  Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits.

Authors:  Jon M Burnham; Justine Shults; Sarah E Dubner; Harjeet Sembhi; Babette S Zemel; Mary B Leonard
Journal:  Arthritis Rheum       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.